CEP152 is a genome maintenance protein disrupted in Seckel syndrome (original) (raw)
Accession codes
Accessions
NCBI Reference Sequence
References
- Nyberg, K.A., Michelson, R.J., Putnam, C.W. & Weinert, T.A. Annu. Rev. Genet. 36, 617–656 (2002).
Article CAS Google Scholar - Cimprich, K.A. & Cortez, D. Nat. Rev. Mol. Cell Biol. 9, 616–627 (2008).
Article CAS Google Scholar - Bonner, W.M. et al. Nat. Rev. Cancer 8, 957–967 (2008).
Article CAS Google Scholar - O'Driscoll, M., Ruiz-Perez, V.L., Woods, C.G., Jeggo, P.A. & Goodship, J.A. Nat. Genet. 33, 497–501 (2003).
Article CAS Google Scholar - Murga, M. et al. Nat. Genet. 41, 891–898 (2009).
Article CAS Google Scholar - Majewski, F. & Goecke, T. Am. J. Med. Genet. 12, 7–21 (1982).
Article CAS Google Scholar - Rauch, A. et al. Science 319, 816–819 (2008).
Article CAS Google Scholar - Griffith, E. et al. Nat. Genet. 40, 232–236 (2008).
Article CAS Google Scholar - Guernsey, D.L. et al. Am. J. Hum. Genet. 87, 40–51 (2010).
Article CAS Google Scholar - Andersen, J.S. et al. Nature 426, 570–574 (2003).
Article CAS Google Scholar - Blachon, S. et al. Genetics 180, 2081–2094 (2008).
Article CAS Google Scholar - Doxsey, S.J., Stein, P., Evans, L., Calarco, P.D. & Kirschner, M. Cell 76, 639–650 (1994).
Article CAS Google Scholar - Lovejoy, C.A. et al. Proc. Natl. Acad. Sci. USA 106, 19304–19309 (2009).
Article CAS Google Scholar - Liu, Q. et al. Genes Dev. 70, 1448–1459 (2000).
Google Scholar - Marti, T.M., Hefner, E., Feeney, L., Natale, V. & Cleaver, J.E. Proc. Natl. Acad. Sci. USA 103, 9891–9896 (2006).
Article CAS Google Scholar
Acknowledgements
We thank all family members who participated in this study, E. Milz, A. Alver and A. Coffey for excellent technical assistance, F. Kokocinski and A. Palotie for experimental design, and C. Kubisch, B. Wirth and K. Boss for critical reading the manuscript. The CINP antibody was a kind gift from D. Cortez (Nashville, Tennessee, USA). This work was supported by the German Federal Ministry of Education and Research (BMBF) by grant numbers 01GM0880 (SKELNET) and 01GM0801 (E-RARE network CRANIRARE) to B.W., the Karadeniz Technical University Research Fund by grant numbers 2008.114.001.02 and 2008.114.001.12 to E.K., the Medical Research Council and Lister Institute to A.P.J. and by the Wellcome Trust, grant 077014/Z/05/Z.
Author information
Author notes
- Ersan Kalay and Gökhan Yigit: These authors contributed equally to this work.
Authors and Affiliations
- Department of Medical Biology, Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey
Ersan Kalay, Bayram Toraman & Ahmet Karagüzel - Institute of Human Genetics, University of Cologne, Cologne, Germany
Gökhan Yigit, Esther Pohl, Yun Li & Bernd Wollnik - Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany
Gökhan Yigit, Esther Pohl, Yun Li, Gudrun Nürnberg, Ingelore Baessmann, Peter Nürnberg & Bernd Wollnik - Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany
Gökhan Yigit, Gudrun Nürnberg, Peter Nürnberg & Bernd Wollnik - Department of Pediatrics, Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey
Yakup Aslan - Chromosome Biology Group, Medical Research Council Clinical Sciences Centre, Imperial College School of Medicine, Hammersmith Hospital, London, UK
Karen E Brown - Medical Research Council (MRC) Human Genetics Unit, Institute of Genetics and Molecular Medicine, Western General Hospital, Edinburgh, UK
Louise S Bicknell, Martin S Taylor & Andrew P Jackson - Department of Medical Genetics, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey
Hülya Kayserili - Department of Pediatric Genetics, Cerrahpasa Medical Faculty, Istanbul University, Istanbul, Turkey
Beyhan Tüysüz - Cologne Center for Genomics, University of Cologne, Cologne, Germany
Gudrun Nürnberg, Ingelore Baessmann & Peter Nürnberg - Department of Women and Child Health, Hospital for Children and Adolescents, University of Leipzig, Leipzig, Germany
Wieland Kiess - Preclinical Target Development and Genomics and Proteomics Core Facilities, German Cancer Research Center, Heidelberg, Germany
Manfred Koegl - Department of Clinical Microbiology, Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey
Kurtulus Buruk - Department of Oral Diagnosis and Radiology, Faculty of Dentistry, Karadeniz Technical University, Trabzon, Turkey
Saadettin Kayipmaz - Department of Radiology, Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey
Sibel Kul - Department of Medical Genetics, Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey
Mevlit Ikbal - Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK
Daniel J Turner, Jan Aerts, Carol Scott & Matthew Hurles - Division of Human Genetics, National Health Laboratory Service and The University of Witwatersrand, Johannesburg, South Africa
Karen Milstein - Centre de Référence pour les Affections Rares Génétique Ophtalmologique, Service de Génétique Médicale, Hôpitaux Universitaires de Strasbourg, Strasbourg, France
Helene Dollfus - Institut für Humangenetik, Universitätsklinikum Essen, Essen, Germany
Dagmar Wieczorek - Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
Han G Brunner - Institute of Medical Genetics, Zürich University, Zürich, Switzerland
Anita Rauch
Authors
- Ersan Kalay
- Gökhan Yigit
- Yakup Aslan
- Karen E Brown
- Esther Pohl
- Louise S Bicknell
- Hülya Kayserili
- Yun Li
- Beyhan Tüysüz
- Gudrun Nürnberg
- Wieland Kiess
- Manfred Koegl
- Ingelore Baessmann
- Kurtulus Buruk
- Bayram Toraman
- Saadettin Kayipmaz
- Sibel Kul
- Mevlit Ikbal
- Daniel J Turner
- Martin S Taylor
- Jan Aerts
- Carol Scott
- Karen Milstein
- Helene Dollfus
- Dagmar Wieczorek
- Han G Brunner
- Matthew Hurles
- Andrew P Jackson
- Anita Rauch
- Peter Nürnberg
- Ahmet Karagüzel
- Bernd Wollnik
Contributions
The project was conceived and the experiments were planned by E.K. and B.W. We would like to note that Y.A. and K.E.B. had a comparable contribution to this study. The review of phenotypes and the sample collection were performed by B.W., E.K., Y.A., A.P.J., H.K., B. Tüysüz, W.K., B. Toraman., S. Kayipmaz, S. Kul, M.I., K.M., H.D., D.W., H.G.B. and A.R. Experiments were performed by E.K., G.Y., K.E.B., E.P., L.S.B., Y.L., M.K., I.B., K.B., D.J.T. and C.S. Data analysis was performed by B.W., E.K., G.N., P.N., A.K., J.A., M.S.T., M.H. and A.P.J. The manuscript was written by B.W., G.Y., E.K. and K.E.B. All aspects of the study were supervised by B.W.
Corresponding authors
Correspondence toErsan Kalay or Bernd Wollnik.
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Rights and permissions
About this article
Cite this article
Kalay, E., Yigit, G., Aslan, Y. et al. CEP152 is a genome maintenance protein disrupted in Seckel syndrome.Nat Genet 43, 23–26 (2011). https://doi.org/10.1038/ng.725
- Received: 09 August 2010
- Accepted: 12 November 2010
- Published: 05 December 2010
- Issue date: January 2011
- DOI: https://doi.org/10.1038/ng.725